Home
Sitemap
Japanese
World Wide
Invester Relations
What's New
Top Message
Top Management Message
Disclosure Policy
Corporate Governance
Compliance
Disclaimer
Reports & Financials
Financial Highlights
Segment Information
Financial Results
Annual Report
Intellectual Property Report
Shareholders & Stock
Shareholders Meeting
Articles of Incorporation
(PDF)
Stock Information
Stock Price
(To Outside Terumo site)
IR Events
IR Calendar
Other
Mail for IR Inquiry
What's NEW
IR News
Jan. 29
Reference of "3rd Quarter Financial Results for FYE 3/2010"
Jan. 28
Presentation material & webcast of "3rd Quarter Financial Results for FYE 3/2010"
Jan. 28
"3rd Quarter Financial Results for FYE 3/2010"
Dec. 29
"Intellectual Property Report"
Dec. 7
"Top Management Message"
IR Press Release
Sep. 3
Terumo and Takeda to Co-promote Takeda’s Ethical Narcotic Formulations
Aug. 31
Teikoku Seiyaku and Terumo reach basic agreement toward comprehensive business partnership of medical narcotic drugs in the cancer pain control domain
June 19
Notice Regarding the Election of Independent Committee Members for the “Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures)”
18KB
Mar. 25
Terumo completes enrolment of 3000 patients in NOBORI 2 – a Nobori® Drug Eluting Stent Trial
Feb. 5
Terumo and Fuji Pharma agree to proceed to capital and business alliance
Other Press Releases >>>
Contents of Investor Relations
Top Message
Top Management Message
Disclosure Policy
Corporate Governance
Compliance
Disclaimer
Reports & Financials
Financial Highlights
Segment Information
Financial Results
Annual Report
Intellectual Property Report
Shareholders & Stock
Shareholders Meeting
Articles of Incorporation
(PDF)
Stock Information
Stock Price
(To Outside Terumo site)
IR Events
IR Calender
Other
Mail for IR Inquiry
